secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001641172-25-022361
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic secures $560K convertible note from Mast Hill; enters $25M equity purchase agreement
--------------------------------------------------------------------------------

- Issued $560,000 convertible promissory note to Mast Hill Fund, 10% OID, 10% interest, convertible at $0.07/share.
- Note warrants issued for 2,000,000 shares at $0.15 exercise price; note secured against most company assets.
- Also entered $25M equity purchase agreement with Mast Hill; issued warrants for 3,350,000 shares.
- Equity purchase price set at 97% of market price or 102% of market alternative price; commitment period up to 24 months.
- Proceeds from note for general working capital; registration rights agreements filed for resale of underlying shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000164117225022361/0001641172-25-022361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000164117225022361/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer